Sustained secretion of human alpha-1-antitrypsin from murine muscle transduced with adeno-associated virus vectors
- PMID: 9826709
- PMCID: PMC24382
- DOI: 10.1073/pnas.95.24.14384
Sustained secretion of human alpha-1-antitrypsin from murine muscle transduced with adeno-associated virus vectors
Abstract
Recombinant adeno-associated virus (AAV) vectors have been used to transduce murine skeletal muscle as a platform for secretion of therapeutic proteins. The utility of this approach for treating alpha-1-antitrypsin (AAT) deficiency was tested in murine myocytes in vitro and in vivo. AAV vectors expressing the human AAT gene from either the cytomegalovirus (CMV) promoter (AAV-C-AT) or the human elongation factor 1-alpha promoter (AAV-E-AT) were examined. In vitro in C2C12 murine myoblasts, the expression levels in transient transfections were similar between the two vectors. One month after transduction, however, the human elongation factor 1 promoter mediated 10-fold higher stable human AAT expression than the CMV promoter. In vivo transduction was performed by injecting doses of up to 1.4 x 10(13) particles into skeletal muscles of several mouse strains (C57BL/6, BALB/c, and SCID). In vivo, the CMV vector mediated higher levels of expression, with sustained serum levels over 800 micrograms/ml in SCID and over 400 micrograms/ml in C57BL/6 mice. These serum concentrations are 100,000-fold higher than those previously observed with AAV vectors in muscle and are at levels which would be therapeutic if achieved in humans. High level expression was delayed for several weeks but was sustained for over 15 wk. Immune responses were dependent upon the mouse strain and the vector dosage. These data suggest that recombinant AAV vector transduction of skeletal muscle could provide a means for replacing AAT or other essential serum proteins but that immune responses may be elicited under certain conditions.
Figures





Similar articles
-
Human Treg responses allow sustained recombinant adeno-associated virus-mediated transgene expression.J Clin Invest. 2013 Dec;123(12):5310-8. doi: 10.1172/JCI70314. Epub 2013 Nov 15. J Clin Invest. 2013. PMID: 24231351 Free PMC article. Clinical Trial.
-
Therapeutic level of functional human alpha 1 antitrypsin (hAAT) secreted from murine muscle transduced by adeno-associated virus (rAAV1) vector.J Gene Med. 2006 Jun;8(6):730-5. doi: 10.1002/jgm.896. J Gene Med. 2006. PMID: 16518879
-
Stable therapeutic serum levels of human alpha-1 antitrypsin (AAT) after portal vein injection of recombinant adeno-associated virus (rAAV) vectors.Gene Ther. 2001 Sep;8(17):1299-306. doi: 10.1038/sj.gt.3301422. Gene Ther. 2001. PMID: 11571566
-
Preclinical evaluation of a recombinant adeno-associated virus vector expressing human alpha-1 antitrypsin made using a recombinant herpes simplex virus production method.Hum Gene Ther. 2011 Feb;22(2):155-65. doi: 10.1089/hum.2010.118. Epub 2010 Dec 12. Hum Gene Ther. 2011. PMID: 20812844 Free PMC article.
-
Insulin Therapy Improves Adeno-Associated Virus Transduction of Liver and Skeletal Muscle in Mice and Cultured Cells.Hum Gene Ther. 2016 Nov;27(11):892-905. doi: 10.1089/hum.2016.073. Epub 2016 Jun 29. Hum Gene Ther. 2016. PMID: 27358030
Cited by
-
Alpha-1-antitrypsin deficiency: current concepts.Lung. 2007 Jul-Aug;185(4):191-201. doi: 10.1007/s00408-007-9009-y. Epub 2007 Jun 12. Lung. 2007. PMID: 17562108 Review.
-
alpha1-Antitrypsin deficiency . 6: new and emerging treatments for alpha1-antitrypsin deficiency.Thorax. 2004 Oct;59(10):904-9. doi: 10.1136/thx.2003.006551. Thorax. 2004. PMID: 15454659 Free PMC article. Review.
-
Consequences of DNA-dependent protein kinase catalytic subunit deficiency on recombinant adeno-associated virus genome circularization and heterodimerization in muscle tissue.J Virol. 2003 Apr;77(8):4751-9. doi: 10.1128/jvi.77.8.4751-4759.2003. J Virol. 2003. PMID: 12663782 Free PMC article.
-
Factor IX expression in skeletal muscle of a severe hemophilia B patient 10 years after AAV-mediated gene transfer.Blood. 2012 Mar 29;119(13):3038-41. doi: 10.1182/blood-2011-09-382317. Epub 2012 Jan 23. Blood. 2012. PMID: 22271447 Free PMC article.
-
Progress with Recombinant Adeno-Associated Virus Vectors for Gene Therapy of Alpha-1 Antitrypsin Deficiency.Hum Gene Ther Methods. 2015 Jun;26(3):77-81. doi: 10.1089/hgtb.2015.086. Hum Gene Ther Methods. 2015. PMID: 26067712 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous